Improved detection of medullary thyroid cancer with radiolabeled antibodies to carcinoembryonic antigen

Journal of Clinical Oncology

Volumn 14, Issue 4, 1996, Pages 1209-1217

  Juweid, M ^a   Sharkey, R M ^a   Behr, T ^a   Swayne, L C ^a   Rubin, A D ^a   Herskovic, T ^a   Hanley, D ^a   Markowitz, A ^a   Dunn, R ^a   Siegel, J ^a   Kamal, T ^a   Goldenberg, D M ^a  

^a CENTER FOR MOLECULAR MEDICINE AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; MONOCLONAL ANTIBODY;

ANTIBODY LABELING; ANTIGEN DETECTION; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; ISOTOPE LABELING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THYROID MEDULLARY CARCINOMA;

EID: 9244257274     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.4.1209     Document Type: Article

References (35)

1. Robbins J, Merino MJ, Boice JD Jr, et al: NIH Conference - Thyroid cancer: A lethal endocrine neoplasm. Ann Intern Med 115:133-147, 1991
2. van Heerden JA, Grand CS, Gharib H, et al: Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg 212:395-401, 1990
3. Talpos GB, Jackson CE, Froelich JW, et al: Localization of residual medullary thyroid cancer by thallium/technetium scintigraphy. Surgery 98:1189-1196, 1985
4. Arnstein NB, Juni JE, Sisson JC, et al: Recurrent medullary carcinoma of the thyroid demonstrated by thallium-201 scintigraphy. J Nucl Med 27:1564-1568, 1986
5. Tisell L-E, Hansson G, Jansson S, et al: Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. Surgery 99:60-66, 1986
6. Tisell L-E, Jansson S: Recent results of reoperative surgery in medullary carcinoma of the thyroid. Wien Klin Wochenschr 100:347-348, 1988
7. Block MA, Jackson CE, Tashjian AH: Management of occult medullary thyroid carcinoma. Arch Surg 113:368-372, 1978
8. Wells SA Jr, Dilley WG, Farndon JA, et al: Early diagnosis and treatment of medullary thyroid carcinoma. Arch Intern Med 145:1248-1252, 1985
9. Busnardo B, Girelli ME, Simioni N, et al: Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow-up of medullary thyroid carcinoma. Cancer 53:278-285, 1984
10. Ishikawa N, Hamada S: Association of medullary carcinoma of the thyroid with carcinoembryonic antigen. Br J Cancer 34:111-115, 1976
11. Wells SA Jr, Haagensen DE Jr, Linehan WM, et al: The detection of elevated plasma levels of carcinoembryonic antigen in patients with suspected or established medullary thyroid carcinoma. Cancer 42:1498-1503, 1978
12. Gold P, Freedman SO: Specific carcinoembryonic antigens of the human digestive system. J Exp Med 122:467-481, 1965
13. Goldenberg DM, DeLand F, Kim E, et al: Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med 298:1384-1388, 1978
14. Rougier PH, Calmettes C, Laplanche A, et al: The value of calcitonin and carcinoembryonic antigen in the treatment and management of non-familial medullary thyroid carcinoma. Cancer 51:855-862, 1983
15. Primus FJ, Newell KD, Blue A, et al: Immunological heterogeneity of carcinoembryonic antigen: Antigenic determinants on carcinoembryonic antigen distinguished by monoclonal antibodies. Cancer Res 43:686-692, 1983
16. Hansen HJ, Goldenberg DM, Newman ES, et al: Characterization of second-generation monoclonal antibodies against carcinoembryonic antigen. Cancer 71:3478-3485, 1993
17. Sharkey RM, Goldenberg DM, Murthy S, et al: Clinical evaluation of tumor targeting with a high-affinity, anticarcinoembryonic-antigen-specitic, murine monoclonal antibody, MN-14. Cancer 71:2082-2096, 1993
18. Sharkey RM, Goldenberg DM, Goldenberg H, et al: Murine monoclonal antibodies against carcinoembryonic antigen: Immunological, pharmacokinetic, and targeting properties in humans. Cancer Res 50:2823-2831, 1990
19. Sharkey RM, Juweid M, Shevitz J, et al: Evaluation of a CDR-grafted (humanized) anti-carcinoembryonic antigen (CEA) monoclonal antibody in preclinical and clinical studies. Cancer Res 55:5935S-5945S, 1995 (suppl)
20. Goldenberg DM, Wlodkowski TJ, Sharkey RM, et al: Colorectal cancer imaging with iodine-123-labeled CEA monoclonal antibody fragments. J Nucl Med 34:61-70, 1993
21. Juweid M, Sharkey RM, Behr T, et al: Targeting and treat\ment of medullary thyroid carcinoma with radiolabeled monoclonal antibodies against carcinoembryonic antigen. Proc Am Soc Clin Oncol 14:422, 1995 (abstr)
22. Juweid M, Sharkey RM, Behr T, et al: Radioimmunotherapy of medullary thyroid carcinoma with I-131-labeled anti-CEA antibodies: Initial results. J Nucl Med (in press)
23. Hansen HJ, Sullivan CL, Sharkey RM, Goldenberg DM: HAMA interference with murine monoclonal antibody-based immunoassays. J Clin Immunoassay 16:294-299, 1993
24. Edington HD, Watson CG, Levine G, et al: Radioimmuno-imaging of metastatic medullary carcinoma of the thyroid gland using an indium-111-labeled monoclonal antibody to CEA. Surgery 104:1004-1010, 1988
25. Zanin DEA, van Dongen A, Hoefnagel CA, et al: Radioimmunoscintigraphy using iodine-131-anti-CEA monoclonal antibodies and thallium-201 scintigraphy in medullary thyroid carcinoma: a case report. J Nucl Med 31:1854-1855, 1990
26. 123I or In-111-labelled monoclonal anti-CEA antibody fragment. Nucl Med 25:227-231, 1986
27. Berche C, Mach JP, Lumbrosco JD, et al: Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: First clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen. Br Med J 285:1447-1451, 1982
28. Peltier P, Curtet C, Chatal JF, et al: Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer. J Nucl Med 34:1267-1273, 1993
29. 2 fragments of anticarcinoembryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma. J Clin Endocrinol Metab 74:157-163, 1992
30. Castillo LA, Yeh SDJ, Leeper RD, et al: Bone scans in bone metastases from functioning thyroid carcinoma. Clin Nucl Med 5:200-209, 1980
31. 99mTc](v)dimercaptosuccinic acid scintigraphy. Br J Surg 76:1278-1281, 1989
32. Ansari AN, Siegel ME, DeQuattro V, et al: Imaging of medullary thyroid carcinoma and hyperfunctioning adrenal medulla using iodine-131 metaiodobenzylguanidine. J Nucl Med 27:1858-1860, 1986
33. Sone T, Fukunaga M, Otsuka N, et al: Metastatic medullary thyroid cancer: Localization with iodine-131 metaiodobenzylguanidine. J Nucl Med 26:604-608, 1985
34. 123I MIBG in the detection of malignancies. Eur J Nucl Med 21:779, 1994 (abstr)
35. Hilditch TE, Connell JM, Elliott A, et al: Poor results with technetium-99m (V) DM5 and iodine-131 MIBG in the imaging of medullary thyroid carcinoma. J Nucl Med 27:1150-1153, 1986